If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User Agreement: www.umlib.nl/taverne-license Take down policy If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl providing details and we will investigate your claim. Download date: 05 Apr. 2020
Our main objective as introduced in Chapter 1 was to gain a deeper understanding of how height is associated with cancer risk later in life. Increased adult-attained height has been consistently associated with increased cancer risk in the literature, yet plausible mechanisms remain to be further elucidated.
Although there is a broad understanding of how early life environmental and genetic processes contribute to adult-attained height, there is still little evidence on how these factors might link to cancer risk. As it has been observed that height increases the risk of a number of different types of cancer and because relative risk estimates in relation to height are very similar across different cancers and in different populations, a common mechanism might be at play. From an environmental perspective we aimed to study these underlying mechanisms by investigating how early life energy restriction during childhood and adolescence influences both adult-attained height and cancer risk. Early life determinants of growth are presumably associated with cancer risk later in life in a direction as expected based on analogy with the height-cancer association.
We also aimed to specifically study height in relation to the risk of postmenopausal Furthermore, a SNP selection approach was applied to identify genetic variants and genes that may link height to cancer risk. We focused on postmenopausal breast cancer and colorectal cancer. Both types of cancer share a subset of risk factors and height has been identified as a convincing risk factor for these cancers according to the World Cancer Research Fund. Germline genetic variants are useful as markers of shared mechanisms between adult-attained height because these are time-independent markers of pathway involvement.
Chapter 2 consists of a systematic literature review and meta-analysis of human observational studies in which the evidence on the association between early life energy restriction and site-specific cancer risk is investigated. Furthermore, specific aspects of early life energy restriction are discussed, such as the timing, duration, and severity of exposure, which may determine whether exposure is associated with an increased or decreased risk of cancer. The systematic review indicated that moderate continuous energy restriction, as studied in animal experimental and human ecological studies, was generally associated with a decreased site-specific cancer risk. The meta-analysis of human observational studies indicated that severe transient early life energy restriction was associated with a 28% increased breast cancer risk and a 16% increased prostate cancer risk, though some of the underlying studies showed null results. The evidence for an association between severe transient early life energy restriction and risk at other cancer sites, i.e. colorectal-, stomach-, pancreas-, ovarian-, and respiratory cancer was either limited or studies were too heterogeneous for pooling. A In Chapter 4, an approach for the selection of genetic variants is presented, which was developed to select genetic variants to identify shared mechanisms linking height to postmenopausal breast-and colorectal cancer risk. The selection method for genetic variants is based on the assumption that genetic variants from GWAS associated with complex diseases or traits tend to co-segregate in regions of low recombination, harboring functionally linked gene clusters. This phenomenon allows for selecting a limited number of genetic variants. This selection approach for genetic variants is of particular interest for large-scale studies with exhaustive bio-samples, i.e. DNA from nails, in which a genomewide approach is not feasible, and will reduce the costs of genotyping and the chance of false-positive findings. The novelty of this method is the comprehensive integration of publically available GWAS repositories, on the basis of which genetic variants associated with complex traits and diseases can be identified, as these are hypothesized to cluster in regions of low recombination. Genomic regions including genetic variants for height and cancer may indicate pathways underlying height-cancer associations. Such genetic variants can serve as timeindependent biomarkers of pathway involvement that may mechanistically explain the established associations. Using our selection method for genetic variants, we identified clusters of genetic variants derived from GWAS data that were associated with adult-attained height and the risk of postmenopausal breast cancer and/or colorectal cancer. This systematic approach identified a limited number of clustered genetic variants, which pinpoint potential shared mechanisms 
